Cargando…

Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation

Detalles Bibliográficos
Autores principales:	Gawałko, Monika, Dobrev, Dobromir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984633/ https://www.ncbi.nlm.nih.gov/pubmed/35402693 http://dx.doi.org/10.1016/j.ijcha.2022.101000

Ejemplares similares

The Management of Postoperative Atrial Fibrillation (POAF): A Systematic Review
por: Meenashi Sundaram, Dakshin, et al.
Publicado: (2023)

Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence?
por: Gawałko, Monika, et al.
Publicado: (2020)

Bedside Tool for Predicting the Risk of Postoperative Atrial Fibrillation After Cardiac Surgery: The POAF Score
por: Mariscalco, Giovanni, et al.
Publicado: (2014)

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2021)

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2020)

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
por: Gawałko, Monika, et al.
Publicado: (2020)

Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
por: Lubbers, Ellen R., et al.
Publicado: (2018)

Compared with matched controls, patients with postoperative atrial fibrillation (POAF) have increased long-term AF after CABG, and POAF is further associated with increased ischemic stroke, heart failure and mortality even after adjustment for AF
por: Thorén, Emma, et al.
Publicado: (2020)

Sleep apnea and atrial fibrillation: Update 2020
por: Linz, Dominik, et al.
Publicado: (2020)

In-depth characterization of a mouse model of postoperative atrial fibrillation
por: Keefe, Joshua A., et al.
Publicado: (2022)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Does weight matter in cryoballoon ablation?
por: Gawałko, Monika, et al.
Publicado: (2023)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

An arrhythmogenic metabolite in atrial fibrillation
por: Krause, Julia, et al.
Publicado: (2023)

Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019)

Direct oral anticoagulation and severe obesity – One size fits all?
por: Fender, Anke C., et al.
Publicado: (2021)

Epicardial Adipose Tissue and Postoperative Atrial Fibrillation
por: Petraglia, Laura, et al.
Publicado: (2022)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Botulinum toxin for prevention of post-operative atrial fibrillation
por: Saljic, Arnela, et al.
Publicado: (2023)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

Comparison of Unipolar and Bipolar Voltage Mapping for Localization of Left Atrial Arrhythmogenic Substrate in Patients With Atrial Fibrillation
por: Nairn, Deborah, et al.
Publicado: (2020)

Calcium dysregulation in atrial fibrillation: the role of CaMKII
por: Heijman, Jordi, et al.
Publicado: (2014)

Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
por: Dobrev, Dobromir, et al.
Publicado: (2022)

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
por: Sutanto, Henry, et al.
Publicado: (2019)

Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism
por: Grammatika Pavlidou, Nefeli, et al.
Publicado: (2023)

Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2020)

Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2023)

Does Epicardial Adipose Tissue Influence Postoperative Atrial Fibrillation?
por: Kogo, Hiroko, et al.
Publicado: (2018)

Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
por: Chen, Gong, et al.
Publicado: (2018)

TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
por: Saljic, Arnela, et al.
Publicado: (2022)

Detection of focal source and arrhythmogenic substrate from body surface potentials to guide atrial fibrillation ablation
por: Feng, Yingjing, et al.
Publicado: (2022)

Postoperative atrial fibrillation and atrial epicardial fat: Is there a link?
por: van der Heijden, Claudia A.J., et al.
Publicado: (2022)

Could We Predict POAF With a Simple Ambulatory Oscillometry Evaluating Aortic Stiffness?
por: Apaydin, Ziya, et al.
Publicado: (2023)

QUest for the Arrhythmogenic Substrate of Atrial fibRillation in Patients Undergoing Cardiac Surgery (QUASAR Study): Rationale and Design
por: van der Does, Lisette J. M. E., et al.
Publicado: (2016)

Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?
por: Wakili, Reza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_40n2a6805ro8kbvmkcmol4f7ub